17. Benefit-Risk Profile of Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG) in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): The PATH study

Authors :: Nan Geloven van
Hans-Peter Hartung
Orell Mielke
Amgad Shebl
Ingemar S. J. Merkies
John-Philip Lawo
Ivo N. van Schaik
Gen Sobue
Vera Bril
Billie L. Durn
David R. Cornblath
Richard A. Lewis
Source :: Clinical Neurophysiology. 131:e7-e8
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: biology
business.industry
Chronic inflammatory demyelinating polyneuropathy
Subcutaneous immunoglobulin
medicine.disease
Risk profile
Sensory Systems
Neurology
Physiology (medical)
Immunology
biology.protein
Medicine
Neurology (clinical)
Antibody
business

Tools